The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome*-Reference-Cited by-同舟云学术

The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome*

Published:2016-12-12 Issue:8 Volume:58 Page:1893-1902
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Falantes Jose F.¹,Márquez-Malaver Francisco J.¹,Knight Teresa¹,Calderón-Cabrera Cristina¹,Martino María L.¹,González Jose¹,Montero Isabel¹,Espigado Ildefonso¹,Pérez-Simón Jose A.¹

Affiliation:

1. Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1267350

Reference32 articles.

1. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

2. Myelodysplastic Syndromes

3. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

4. A prognostic score for patients with lower risk myelodysplastic syndrome

5. Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients;Leukemia Research;2023-11

2. Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes;Blood Advances;2023-06-30

3. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes;Cancer Epidemiology;2022-02

4. Comorbidities and frailty predict outcome of patients with myelodysplastic syndromes. Should we integrate them in novel prognostic scoring systems?;Journal of Geriatric Oncology;2021-09

5. Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study;Blood Advances;2021-03-03